204 related articles for article (PubMed ID: 3118693)
1. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
[TBL] [Abstract][Full Text] [Related]
2. Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias.
Facchini M; Bonazzi O; Priori SG; Varisco T; Zuanetti G; Schwartz PJ
Eur Heart J; 1988 May; 9(5):462-70. PubMed ID: 3402461
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of penticainide (CM 7857), a novel class I antiarrhythmic drug--comparison with disopyramide.
Pfisterer M; Munoz A; Burkart F
J Cardiovasc Pharmacol; 1988 Aug; 12(2):247-51. PubMed ID: 2459557
[TBL] [Abstract][Full Text] [Related]
4. [The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram].
Böcker K; Köhler E; Seipel L; Loogen F
Z Kardiol; 1982 Dec; 71(12):839-45. PubMed ID: 7164536
[TBL] [Abstract][Full Text] [Related]
5. Effects of mexiletine, propafenone and flecainide on signal-averaged electrocardiogram.
Lombardi F; Finocchiaro ML; Dalla Vecchia L; Rech R; Castelli A; Pastine J; Cappiello E
Eur Heart J; 1992 Apr; 13(4):517-25. PubMed ID: 1600992
[TBL] [Abstract][Full Text] [Related]
6. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
Tanabe T
Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
[TBL] [Abstract][Full Text] [Related]
7. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
Kjekshus J; Bathen J; Orning OM; Storstein L
Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
Tanabe T; Takahashi K; Yoshioka K; Goto Y
Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
[TBL] [Abstract][Full Text] [Related]
11. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
[TBL] [Abstract][Full Text] [Related]
12. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
Kim SG; Mercando AD; Tam S; Fisher JD
J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173
[TBL] [Abstract][Full Text] [Related]
13. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
[TBL] [Abstract][Full Text] [Related]
14. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
Naccarella F; Bracchetti D; Palmieri M; Cantelli I; Bertaccini P; Ambrosioni E
Am Heart J; 1985 Apr; 109(4):833-40. PubMed ID: 3885700
[TBL] [Abstract][Full Text] [Related]
15. Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
Takanaka C; Nonokawa M; Machii T; Lee S; Kato H; Haruna M; Yabe S
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2130-3. PubMed ID: 1279613
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.
Campbell JK; Marshall RJ; Winslow E
Br J Pharmacol; 1991 Oct; 104(2):433-9. PubMed ID: 1797309
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
Breithardt G; Seipel L; Lersmacher J; Abendroth RR
J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
[No Abstract] [Full Text] [Related]
18. Comparative study on the proarrhythmic effects of some antiarrhythmic agents.
Dhein S; Müller A; Gerwin R; Klaus W
Circulation; 1993 Feb; 87(2):617-30. PubMed ID: 8425305
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
[TBL] [Abstract][Full Text] [Related]
20. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Klempt HW; Nayebagha A; Fabry E
Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
